⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7043388 | 1.00 | — | — | |
| SCHEMBL7045770 | 1.00 | — | — | |
| SCHEMBL104183 | 0.98 | — | — | |
| SCHEMBL9486545 | 0.94 | — | — | |
| SCHEMBL7041950 | 0.94 | — | — | |
| SCHEMBL9485880 | 0.92 | — | — | |
| SCHEMBL426888 | 0.91 | — | — | |
| SCHEMBL3880695 | 0.85 | — | — | |
| SCHEMBL2268394 | 0.82 | — | — | |
| SCHEMBL6715403 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220379559-A1 | RESIN CASSETTES WITH LIQUID INHIBITOR BEDS TO MINIMIZE GHOSTING DURING ADDITIVE MANUFACTURING | CARBON INC (US) | 2022-12-01 | — | — | US | disclosed |
| US-11446871-B2 | Resin cassettes with liquid inhibitor beds to minimize ghosting during additive manufacturing | CARBON, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210094231-A1 | RESIN CASSETTES WITH LIQUID INHIBITOR BEDS TO MINIMIZE GHOSTING DURING ADDITIVE MANUFACTURING | CARBON INC (US) | 2021-04-01 | — | — | US | disclosed |
| EP-1295602-A1 | OXYGEN-CONTAINING OPHTHALMIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-20020164379-A1 | Oxygen-containing ophthalmic composition | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2002-11-07 | — | — | US | disclosed |
| WO-1994007475-A9 | PERFUSION OF PERFLUOROCARBON COMPOUND EMULSION DURING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | — | 1994-06-09 | — | — | WO | disclosed |
| WO-1994007475-A1 | PERFUSION OF PERFLUOROCARBON COMPOUND EMULSION DURING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | FORMAN B MERVYN (US) | 1994-04-14 | — | — | WO | disclosed |
| US-5262442-A | Fluosol for injection for oxygen transport | ALPHA THERAPEUTIC CORPORATION (US) | 1993-11-16 | — | — | US | disclosed |
| EP-0548601-A1 | Process for rapid thawing and storage of frozen fluorocarbon emulsion, and resultant product | ALPHA THERAPEUTIC CORPORATION (US) | 1993-06-30 | — | — | EP | disclosed |
| US-5180676-A | Suspension of cells in a liquid fluorocarbon having dissolved oxygen in a culture medium | TEIJIN LIMITED (JP) | 1993-01-19 | — | — | US | disclosed |
| EP-0164813-B1 | METHOD OF CULTIVATING ANIMAL OR PLANT CELLS | TEIJIN LIMITED (JP) | 1991-10-09 | — | — | EP | disclosed |
| EP-0164813-A2 | Method of cultivating animal or plant cells | TEIJIN LIMITED (JP) | 1985-12-18 | — | — | EP | disclosed |
| EP-0033402-B1 | PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD | The Green Cross Corporation (JP) | 1983-09-07 | — | — | EP | disclosed |
| US-4186253-A | RINGER'S SOLUTION WITH INCREASED POTASSIUM ION, ALBUMIN, PERFLUOROCARBON COMPOUND, EMULSIFIER | THE GREEN CROSS CORPORATION (JP) | 1980-01-29 | — | — | US | disclosed |